| The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with … L Urso, L Evangelista, P Alongi, N Quartuccio, C Cittanti, I Rambaldi, ... Cancers 14 (23), 5869, 2022 | 13 | 2022 |
| 18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? L Urso, F Lancia, N Ortolan, M Frapoli, M Rauso, P Artioli, C Cittanti, ... Clinical and Translational Imaging 10 (6), 687-695, 2022 | 12 | 2022 |
| The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review M Caracciolo, A Castello, L Urso, F Borgia, N Ortolan, L Uccelli, C Cittanti, ... Cancers 14 (20), 5036, 2022 | 12 | 2022 |
| Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) M Bauckneht, F Lanfranchi, D Albano, L Triggiani, F Linguanti, L Urso, ... Journal of Nuclear Medicine, 2024 | 7 | 2024 |
| PET criteria by cancer type from imaging interpretation to treatment response assessment: beyond FDG PET score F Dondi, A Lazzarato, J Gorica, P Guglielmo, F Borgia, R Filice, A Vento, ... Life 13 (3), 611, 2023 | 7 | 2023 |
| 18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes … N Quartuccio, P Alongi, L Urso, N Ortolan, F Borgia, M Bartolomei, ... Cancers 15 (10), 2715, 2023 | 5 | 2023 |
| Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT L Urso, A Castello, G Treglia, S Panareo, A Nieri, I Rambaldi, ... Diagnostics 13 (4), 606, 2023 | 5 | 2023 |
| Uncommon solitary nasal extramedullary plasmacytoma detected by 18F-FDG PET/CT L Urso, N Ortolan, S Panareo, A Stefanelli, A Cuneo, M Bartolomei Hellenic Journal of Nuclear Medicine 24 (3), 265-266, 2021 | 5 | 2021 |
| Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma C Bianchini, M Caracciolo, L Urso, A Ciorba, A Bonsembiante, ... Acta Otorhinolaryngologica Italica 43 (4), 235, 2023 | 4 | 2023 |
| Is there a role for FAPI PET in urological cancers? N Ortolan, L Urso, I Zamberlan, L Filippi, NM Buffi, C Cittanti, L Uccelli, ... Molecular Diagnosis & Therapy 28 (6), 721-725, 2024 | 1 | 2024 |
| ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after … L Urso, C Cittanti, L Manco, N Ortolan, F Borgia, A Malorgio, G Scribano, ... Diagnostics 14 (12), 1264, 2024 | | 2024 |
| Value of semiquantitative parameters derived from 18F-FDG PET/CT to predict 3-years-disease-free survival in patients affected by grade III breast cancer with different luminal … N Quartuccio, L Urso, P Alongi, I Rambaldi, N Ortolan, F Borgia, A Nieri, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| Value of semiquantitative parameters derived from 18F-FDG PET/CT to predict response to neoadjuvant chemotherapy in a cohort of patients with different luminal types of breast … L Urso, P Alongi, N Quartuccio, L Evangelista, I Rambaldi, N Ortolan, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| Incidental Findings of Acute Myeloid Leukemia in Sjögren's Syndrome Detected by Nuclear Medicine Techniques A Castello, M Caracciolo, L Urso, N Ortolan, A Nieri, S Panareo, ... Indian Journal of Nuclear Medicine 37 (3), 279-280, 2022 | | 2022 |
| Prospective evaluation of glucose metabolism variations assessed with FDG PET/CT in a cohort of NET patients treated with PRRT L Urso, S Panareo, A Castello, M Caracciolo, I Zamberlan, N Ortolan, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 48 (SUPPL 1 …, 2021 | | 2021 |
| Role of volumetric parameters on 68Ga-DOTATOC PET/CT in NET patients treated with PRRT L Urso, M Caracciolo, N Ortolan, I Zamberlan, A Castello, E Tonini, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 48 (SUPPL 1 …, 2021 | | 2021 |
| Impact on the long-term prognosis of FDG PET/CT in luminal breast cancer M Caracciolo, L Urso, L Evangelista, S Panareo, N Quartuccio, N Ortolan, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 48 (SUPPL 1), S51-S52, 2021 | | 2021 |
| O10 Guiding metastasis-directed therapy with different PET/CT radiotracers affects distant but not local disease control in oligorecurrent hormone-sensitive prostate cancer … F Lanfranchi, L Belgioia, D Albano, L Triggiani, F Linguanti, L Urso, ... | | |
